155 related articles for article (PubMed ID: 17214722)
1. Neutrophilic eccrine hidradenitis in non-small cell lung cancer.
Lee SG; In SG; Shin JH; Choi GS; Kim YC
Int J Dermatol; 2007 Jan; 46(1):59-60. PubMed ID: 17214722
[TBL] [Abstract][Full Text] [Related]
2. Neutrophilic eccrine hidradenitis secondary to topotecan.
Marini M; Wright D; Ropolo M; Abbruzzese M; Casas G
J Dermatolog Treat; 2002 Mar; 13(1):35-7. PubMed ID: 12006137
[TBL] [Abstract][Full Text] [Related]
3. [Neutrophilic eccrine hidradenitis associated with relapse of acute myeloblastic leukemia].
Saada V; Aractingi S; Leblond V; Marinho E; Frances C; Chosidow O
Ann Dermatol Venereol; 1998 Jul; 125(6-7):420-2. PubMed ID: 9747299
[TBL] [Abstract][Full Text] [Related]
4. A case of recurrent Sweet's syndrome in an 80-year-old man: a clue to an underlying malignancy.
Choi HJ; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
Int J Dermatol; 2006 Apr; 45(4):457-9. PubMed ID: 16650178
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
[TBL] [Abstract][Full Text] [Related]
6. Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.
Srivastava M; Scharf S; Meehan SA; Polsky D
J Am Acad Dermatol; 2007 Apr; 56(4):693-6. PubMed ID: 17109994
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic eccrine hidradenitis: a case report of an unusual annular presentation.
Headley CM; Ioffreda MD; Zaenglein AL
Cutis; 2005 Feb; 75(2):93-7. PubMed ID: 15773529
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
11. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
[TBL] [Abstract][Full Text] [Related]
12. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
Blumenschein GR; Khuri FR; von Pawel J; Gatzemeier U; Miller WH; Jotte RM; Le Treut J; Sun SL; Zhang JK; Dziewanowska ZE; Negro-Vilar A
J Clin Oncol; 2008 Apr; 26(11):1879-85. PubMed ID: 18398153
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
Park JO; Kim SW; Ahn JS; Suh C; Lee JS; Jang JS; Cho EK; Yang SH; Choi JH; Heo DS; Park SY; Shin SW; Ahn MJ; Lee JS; Yun YH; Lee JW; Park K
J Clin Oncol; 2007 Nov; 25(33):5233-9. PubMed ID: 18024869
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C
Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204
[TBL] [Abstract][Full Text] [Related]
17. Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer.
De Giorgi U; Rosti G; Ciucci G; Kopf B; Minzi C; Argnani M; Marangolo M
Bone Marrow Transplant; 2007 Oct; 40(8):735-9. PubMed ID: 17700603
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
Hirose T; Sugiyama T; Kusumoto S; Shirai T; Nakashima M; Yamaoka T; Okuda K; Ogura K; Ohnishi T; Ohmori T; Adachi M
Anticancer Res; 2009 May; 29(5):1733-8. PubMed ID: 19443395
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
20. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis'.
Hurt MA; Halvorson RD; Petr FC; Cooper JT; Friedman DJ
Arch Dermatol; 1990 Jan; 126(1):73-7. PubMed ID: 2404465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
